Overview

Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children

Status:
Recruiting

Trial end date:
2023-06-01

Target enrollment:

Participant gender:

Summary

This is an experimental non-randomized clinical study aimed at expanding the indications for the use of biological drugs with the aim of using them for the pathogenetic therapy of children with congenital ichthyosis.

Phase:

Phase 4

Details

Lead Sponsor:

National Medical Research Center for Children's Health, Russian Federation

Treatments:

Ustekinumab